Reply to: ‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.’ by D. Fabrizio et al. McGrail, DJ, Pilié, PG, Rashid, NU, Voorwerk, L, Slagter, M, Kok, M, Jonasch, E, Khasraw, Mustafa, Heimberger, AB, Ueno, NT, Ferrarotto, R, Chang, JT and Lin, SY 2021, Reply to: ‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.’ by D. Fabrizio et al., Annals of Oncology, vol. 32, no. 9, pp. 1194-1197, doi: 10.1016/j.annonc.2021.06.017. Title Reply to: ‘Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.’ by D. Fabrizio et al. Author(s) McGrail, DJ Pilié, PG Rashid, NU Voorwerk, L Slagter, M Kok, M Jonasch, E Khasraw, Mustafa orcid.org/0000-0003-3249-9849 Heimberger, AB Ueno, NT Ferrarotto, R Chang, JT Lin, SY Journal name Annals of Oncology Volume number 32 Issue number 9 Start page 1194 End page 1197 Total pages 4 Publisher Elsevier BV Place of publication England Publication date 2021-09-01 ISSN 0923-7534 1569-8041 DOI 10.1016/j.annonc.2021.06.017 Indigenous content off Field of Research 1112 Oncology and Carcinogenesis HERDC Research category C4 Letter or note Persistent URL http://hdl.handle.net/10536/DRO/DU:30155610 Document type: Journal Article Collections: Faculty of Health School of Medicine Related Links Link Description Connect to published version Go to link with your DU access privileges   Connect to Elements publication management system Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Versions Version Filter Type Mon, 20 Sep 2021, 08:11:31 EST Mon, 20 Sep 2021, 08:14:58 EST Mon, 11 Oct 2021, 15:08:27 EST Thu, 11 Nov 2021, 15:15:14 EST Thu, 11 Nov 2021, 15:16:32 EST Thu, 11 Nov 2021, 15:45:23 EST Filtered Full Citation counts:   Cited 0 times in TR Web of Science Cited 0 times in Scopus Search Google Scholar Access Statistics: 14 Abstract Views  -  Detailed Statistics Created: Mon, 20 Sep 2021, 08:11:31 EST